Inventor · disambiguated record
Sylvie Jorieux
Also filed as: JORIEUX SYLVIE
8 granted patents·7 pending applications·76 citations·filing 2003–2016
85Inventor score
Files withLAB FRANCAIS DU FRACTIONNEMENT7LFB BIOTECHNOLOGIES2BEHRENS CHRISTIAN1BOUREL DOMINIQUE1FONTAYNE ALEXANDRE1
Top patents by PatentIndex Score
15 records- 0190US7713524B2Use of ADCC-optimized antibodies for treating low-responder patientsLFB BIOTECHNOLOGIES·Filed 2004·Granted May 11, 2010·34 cites·10 claims
- 0288USRE45992EOptimized FC variantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2010·Granted May 3, 2016·15 cites·10 claims
- 0388US8742074B2Optimized FC variantsBEHRENS CHRISTIAN·Filed 2010·Granted Jun 3, 2014·17 cites·9 claims
- 0483US8501171B2Use of ADCC-optimized antibodies for treating weak patientsBOUREL DOMINIQUE·Filed 2010·Granted Aug 6, 2013·9 cites·10 claims
- 0568USRE46585EOptimized FC variantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2010·Granted Oct 24, 2017·1 cites·22 claims
- 0661US9109020B2Use of ADCC-optimized antibodies for treating weak patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 0757US2009081216A1Treatment of pathologies which escape the immune response, using optimized antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2008·Application pending·0 cites
- 0854US9879089B2Use of ADCC-optimized antibodies for treating low-responder patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 30, 2018·0 cites·14 claims
- 0953US2007218052A1Novel lgG3 Antibodies for Stimulating PhagocytosisLABOPRATOIRE FRANCAIS DU FRACT·Filed 2004·Application pending·0 cites
- 1050US2005271652A1Treatment of pathologies which escape the immune response, using optimised antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Application pending·0 cites
- 1147US2007015239A1Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Application pending·0 cites
- 1241US2009029393A1Method for preparing antibodies selective for activating fc receptorsLFB BIOTECHNOLOGIES·Filed 2006·Application pending·0 cites
- 1337US2019388506A1Factor h fragment for use as an anti-angiogenic agentUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2016·Application pending·0 cites
- 1436US8404241B2Anti-rhesus D monoclonal antibodyGAUCHER CHRISTINE·Filed 2010·Granted Mar 26, 2013·0 cites·20 claims
- 1533US2014378663A1Fc variants with reduced effector functionsFONTAYNE ALEXANDRE·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →